Portfolio Holdings Detail for ISIN IE00BD93YH54
| Stock Name / Fund | iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Dist) |
| Issuer | Blackrock |
| Entity holding fund | iShares VI Public Limited Company |
| Entity Type | |
| Entity LEI | 549300VML6THE3JJOS76 |
| ETF Ticker | SPMD(USD) LSE |
| ETF Ticker | SPMD.LS(USD) CXE |
| ETF Ticker | SPMD.L(GBP) LSE |
Holdings detail for IQV
| Stock Name | IQVIA Holdings Inc |
| Ticker | IQV(USD) NYSE |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US46266C1053 |
| LEI | 549300W3R20NM4KQPH86 |
Show aggregate IQV holdings
News associated with IQV
- IQVIA Holdings Inc. (NYSE:IQV) Receives Average Rating of “Moderate Buy” from Brokerages
- IQVIA Holdings Inc. (NYSE:IQV – Get Free Report) has been assigned an average rating of “Moderate Buy” from the twenty-two analysts that are covering the firm, Marketbeat reports. Five analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has given a strong buy rating to the company. […] - 2025-04-11 05:06:58
- Arrowstreet Capital Limited Partnership Lowers Holdings in IQVIA Holdings Inc. (NYSE:IQV)
- Arrowstreet Capital Limited Partnership reduced its stake in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 21.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 37,762 shares of the medical research company’s stock after selling 10,501 […] - 2025-04-07 08:08:53
- Blair William & Co. IL Purchases 1,699 Shares of IQVIA Holdings Inc. (NYSE:IQV)
- Blair William & Co. IL increased its position in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 42.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,742 shares of the medical research company’s stock after purchasing an additional 1,699 […] - 2025-04-03 08:34:47
- IQVIA Holdings Inc. (NYSE:IQV) Stock Position Boosted by LPL Financial LLC
- LPL Financial LLC grew its stake in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 1.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 96,506 shares of the medical research company’s stock after buying an additional 1,311 shares during the quarter. […] - 2025-04-01 10:02:49
- IQVIA Holdings is Now Oversold (IQV)
- Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me - 2025-03-31 15:57:03
- Intech Investment Management LLC Increases Holdings in IQVIA Holdings Inc. (NYSE:IQV)
- Intech Investment Management LLC grew its stake in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 159.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,444 shares of the medical research company’s stock after acquiring an additional 1,501 shares during the quarter. Intech […] - 2025-03-25 08:31:01
- We Did The Math VOTE Can Go To $81
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-03-20 10:36:01
- IQVIA Holdings Inc. (NYSE:IQV) Receives $249.05 Consensus Price Target from Analysts
- IQVIA Holdings Inc. (NYSE:IQV – Get Free Report) has earned an average rating of “Moderate Buy” from the twenty-one research firms that are presently covering the firm, Marketbeat.com reports. Four research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has assigned a strong buy rating to […] - 2025-03-20 05:48:44
- Is IQVIA Holdings Stock Underperforming the Dow?
- IQVIA Holdings has significantly underperformed the Dow over the past year, yet analysts remain strongly bullish on the stock’s prospects. - 2025-03-13 16:41:43
- Victory Capital Management Inc. Cuts Stock Position in IQVIA Holdings Inc. (NYSE:IQV)
- Victory Capital Management Inc. trimmed its stake in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 9.2% during the 4th quarter, HoldingsChannel reports. The fund owned 88,756 shares of the medical research company’s stock after selling 9,038 shares during the quarter. Victory Capital Management Inc.’s holdings in IQVIA were worth $17,441,000 as of its most […] - 2025-03-12 07:55:05
- IQVIA (NYSE:IQV) Downgraded to “Hold” Rating by StockNews.com
- IQVIA (NYSE:IQV – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a report issued on Wednesday. Several other research analysts have also recently weighed in on the company. Barclays reduced their price target on IQVIA from $255.00 to $235.00 and set an “overweight” rating […] - 2025-03-12 06:18:54
- SBI Securities Co. Ltd. Invests $60,000 in IQVIA Holdings Inc. (NYSE:IQV)
- SBI Securities Co. Ltd. purchased a new position in IQVIA Holdings Inc. (NYSE:IQV – Free Report) in the 4th quarter, Holdings Channel reports. The institutional investor purchased 307 shares of the medical research company’s stock, valued at approximately $60,000. Other institutional investors and hedge funds have also recently modified their holdings of the company. Capital […] - 2025-03-11 07:45:03
- IQVIA (NYSE:IQV) Raised to “Buy” at StockNews.com
- IQVIA (NYSE:IQV – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a report issued on Tuesday. A number of other research analysts have also commented on IQV. Robert W. Baird cut their target price on IQVIA from $212.00 to $210.00 and set a “neutral” rating for the […] - 2025-03-06 06:57:23
- IQVIA (NYSE:IQV) Reaches New 52-Week Low Following Analyst Downgrade
- IQVIA Holdings Inc. (NYSE:IQV – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Wednesday after Citigroup lowered their price target on the stock from $225.00 to $210.00. Citigroup currently has a neutral rating on the stock. IQVIA traded as low as $179.28 and last traded at $183.75, with a […] - 2025-03-05 06:30:51
- IQVIA Holdings Stock: Analyst Estimates & Ratings
- IQVIA Holdings has trailed the broader market over the past year, but analysts on Wall Street maintain a very bright outlook on the stock’s growth prospects. - 2025-02-20 14:51:38
- IQVIA (NYSE:IQV) Price Target Cut to $232.00 by Analysts at JPMorgan Chase & Co.
- IQVIA (NYSE:IQV – Get Free Report) had its target price cut by research analysts at JPMorgan Chase & Co. from $240.00 to $232.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has an “overweight” rating on the medical research company’s stock. JPMorgan Chase & Co.‘s price objective would indicate a potential upside of […] - 2025-02-20 09:37:00
- NVIDIA's Rise Puts These 3 Healthcare Stocks in the Spotlight
- ILMN, IQV and DXCM are leveraging AI advancements to drive innovation in genomics, clinical research and diabetes management. - 2025-02-18 17:35:00
- Empowered Funds LLC Has $946,000 Stake in IQVIA Holdings Inc. (NYSE:IQV)
- Empowered Funds LLC grew its stake in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 40.0% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 4,813 shares of the medical research company’s stock after purchasing an additional 1,376 shares during the period. Empowered Funds LLC’s […] - 2025-02-18 08:18:54
- Apollon Wealth Management LLC Sells 1,296 Shares of IQVIA Holdings Inc. (NYSE:IQV)
- Apollon Wealth Management LLC lessened its position in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 26.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,578 shares of the medical research company’s stock after selling 1,296 shares during the quarter. Apollon Wealth Management […] - 2025-02-13 09:44:50
- Stratos Wealth Partners LTD. Sells 319 Shares of IQVIA Holdings Inc. (NYSE:IQV)
- Stratos Wealth Partners LTD. reduced its stake in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 5.3% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 5,725 shares of the medical research company’s stock after selling 319 shares during the quarter. Stratos Wealth Partners LTD.’s holdings in IQVIA were worth $1,125,000 […] - 2025-02-10 23:56:44
- Retirement Systems of Alabama Cuts Stock Holdings in IQVIA Holdings Inc. (NYSE:IQV)
- Retirement Systems of Alabama cut its stake in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 1.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 37,333 shares of the medical research company’s stock after selling 495 shares […] - 2025-02-10 22:28:50
- IQVIA Holdings Inc. (NYSE:IQV) Shares Sold by abrdn plc
- abrdn plc decreased its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 12.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 71,965 shares of the medical research company’s stock after selling 10,137 shares during the period. […] - 2025-02-08 16:16:43
- DAVENPORT & Co LLC Trims Stake in IQVIA Holdings Inc. (NYSE:IQV)
- DAVENPORT & Co LLC lowered its position in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 88.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,296 shares of the medical research company’s stock after selling 17,518 shares during the quarter. DAVENPORT […] - 2025-02-08 09:10:56
- Caprock Group LLC Sells 288 Shares of IQVIA Holdings Inc. (NYSE:IQV)
- Caprock Group LLC decreased its stake in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 9.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,715 shares of the medical research company’s stock after selling 288 shares during the quarter. […] - 2025-02-05 10:09:00
- IQVIA (NYSE:IQV) Price Target Cut to $235.00 by Analysts at Barclays
- IQVIA (NYSE:IQV – Get Free Report) had its price target lowered by equities research analysts at Barclays from $255.00 to $235.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the medical research company’s stock. Barclays‘s target price would suggest a potential upside of […] - 2025-02-05 08:44:47
- Fund Update: Crestwood Advisors Group, LLC Just Disclosed New Holdings
- Crestwood Advisors Group, LLC just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 12-31-2024 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-02-04 16:53:49
iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Dist) IQV holdings
| Date | Number of IQV Shares Held | Base Market Value of IQV Shares | Local Market Value of IQV Shares | Change in IQV Shares Held | Change in IQV Base Value | Current Price per IQV Share Held | Previous Price per IQV Share Held |
|---|
| 2025-04-17 (Thursday) | 20,008 | USD 2,879,351 | USD 2,879,351 | | | | |
| 2025-04-16 (Wednesday) | 20,008 | USD 2,969,988 | USD 2,969,988 | | | | |
| 2025-04-15 (Tuesday) | 20,008 | USD 2,984,193 | USD 2,984,193 | | | | |
| 2025-04-14 (Monday) | 19,657 | USD 2,966,634 | USD 2,966,634 | 54 | USD 113,417 | USD 150.92 | USD 145.55 |
| 2025-04-11 (Friday) | 19,603 | USD 2,853,217 | USD 2,853,217 | 0 | USD 45,675 | USD 145.55 | USD 143.22 |
| 2025-04-10 (Thursday) | 19,603 | USD 2,807,542 | USD 2,807,542 | 0 | USD -270,521 | USD 143.22 | USD 157.02 |
| 2025-04-09 (Wednesday) | 19,603 | USD 3,078,063 | USD 3,078,063 | -158 | USD 222,796 | USD 157.02 | USD 144.49 |
| 2025-04-08 (Tuesday) | 19,761 | USD 2,855,267 | USD 2,855,267 | 80 | USD -156,123 | USD 144.49 | USD 153.01 |
| 2025-04-07 (Monday) | 19,681 | USD 3,011,390 | USD 3,011,390 | 0 | USD -33,851 | USD 153.01 | USD 154.73 |
| 2025-04-04 (Friday) | 19,681 | USD 3,045,241 | USD 3,045,241 | 160 | USD -358,636 | USD 154.73 | USD 174.37 |
| 2025-04-02 (Wednesday) | 19,521 | USD 3,403,877 | USD 3,403,877 | 77 | USD 74,286 | USD 174.37 | USD 171.24 |
| 2025-04-01 (Tuesday) | 19,444 | USD 3,329,591 | USD 3,329,591 | -237 | USD -140,169 | USD 171.24 | USD 176.3 |
| 2025-03-31 (Monday) | 19,681 | USD 3,469,760 | USD 3,469,760 | 1,240 | USD 198,511 | USD 176.3 | USD 177.39 |
| 2025-03-28 (Friday) | 18,441 | USD 3,271,249 | USD 3,271,249 | 158 | USD -7,990 | USD 177.39 | USD 179.36 |
| 2025-03-27 (Thursday) | 18,283 | USD 3,279,239 | USD 3,279,239 | 307 | USD 43,199 | USD 179.36 | USD 180.02 |
| 2025-03-26 (Wednesday) | 17,976 | USD 3,236,040 | USD 3,236,040 | 787 | USD 118,127 | USD 180.02 | USD 181.39 |
| 2025-03-25 (Tuesday) | 17,189 | USD 3,117,913 | USD 3,117,913 | 535 | USD 18,437 | USD 181.39 | USD 186.11 |
| 2025-03-24 (Monday) | 16,654 | USD 3,099,476 | USD 3,099,476 | -79 | USD -11,021 | USD 186.11 | USD 185.89 |
| 2025-03-21 (Friday) | 16,733 | USD 3,110,497 | USD 3,110,497 | | | | |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of IQV by Blackrock for IE00BD93YH54
Show aggregate share trades of IQV| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-04-14 | BUY | 54 | | | 150.920* | | 166.01 |
| 2025-04-09 | SELL | -158 | | | 157.020* | | 170.76 Profit of 26,981 on sale |
| 2025-04-08 | BUY | 80 | | | 144.490* | | 173.39 |
| 2025-04-04 | BUY | 160 | | | 154.730* | | 178.27 |
| 2025-04-02 | BUY | 77 | | | 174.370* | | 178.83 |
| 2025-04-01 | SELL | -237 | | | 171.240* | | 180.10 Profit of 42,683 on sale |
| 2025-03-31 | BUY | 1,240 | | | 176.300* | | 180.85 |
| 2025-03-28 | BUY | 158 | | | 177.390* | | 181.72 |
| 2025-03-27 | BUY | 307 | | | 179.360* | | 182.51 |
| 2025-03-26 | BUY | 787 | | | 180.020* | | 183.75 |
| 2025-03-25 | BUY | 535 | | | 181.390* | | 186.11 |
| 2025-03-24 | SELL | -79 | | | 186.110* | | 0.00 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of IQV
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-04-17 | 324,425 | 18 | 1,216,250 | 26.7% |
| 2025-04-16 | 292,610 | 1 | 547,156 | 53.5% |
| 2025-04-15 | 193,789 | 4,211 | 507,438 | 38.2% |
| 2025-04-14 | 255,301 | 0 | 1,064,543 | 24.0% |
| 2025-04-11 | 331,211 | 6,714 | 1,060,943 | 31.2% |
| 2025-04-10 | 457,258 | 14,839 | 1,364,127 | 33.5% |
| 2025-04-09 | 453,896 | 1,255 | 4,327,629 | 10.5% |
| 2025-04-08 | 525,210 | 0 | 1,237,706 | 42.4% |
| 2025-04-07 | 794,515 | 11 | 1,551,514 | 51.2% |
| 2025-04-04 | 567,831 | 329 | 1,174,353 | 48.4% |
| 2025-04-03 | 801,596 | 100 | 1,254,845 | 63.9% |
| 2025-04-02 | 285,256 | 0 | 726,405 | 39.3% |
| 2025-04-01 | 317,971 | 26 | 507,278 | 62.7% |
| 2025-03-31 | 601,065 | 102 | 843,710 | 71.2% |
| 2025-03-28 | 320,581 | 311 | 659,161 | 48.6% |
| 2025-03-27 | 251,179 | 62 | 663,614 | 37.9% |
| 2025-03-26 | 286,464 | 15 | 638,637 | 44.9% |
| 2025-03-25 | 299,757 | 269 | 674,618 | 44.4% |
| 2025-03-24 | 219,777 | 217 | 329,776 | 66.6% |
| 2025-03-21 | 332,141 | 0 | 531,380 | 62.5% |
| 2025-03-20 | 318,731 | 85 | 504,617 | 63.2% |
| 2025-03-19 | 201,696 | 10 | 391,808 | 51.5% |
| 2025-03-18 | 344,545 | 8 | 563,572 | 61.1% |
| 2025-03-17 | 209,013 | 0 | 512,726 | 40.8% |
| 2025-03-14 | 210,518 | 78 | 371,366 | 56.7% |
| 2025-03-13 | 262,681 | 221 | 436,510 | 60.2% |
| 2025-03-12 | 367,223 | 228 | 540,128 | 68.0% |
| 2025-03-11 | 466,262 | 477 | 642,419 | 72.6% |
| 2025-03-10 | 545,146 | 396 | 818,652 | 66.6% |
| 2025-03-07 | 401,737 | 128 | 773,376 | 51.9% |
| 2025-03-06 | 270,317 | 666 | 423,010 | 63.9% |
| 2025-03-05 | 176,260 | 502 | 331,963 | 53.1% |
| 2025-03-04 | 367,120 | 145 | 646,366 | 56.8% |
| 2025-03-03 | 311,703 | 0 | 556,519 | 56.0% |
| 2025-02-28 | 334,890 | 1,079 | 554,310 | 60.4% |
| 2025-02-27 | 383,331 | 10 | 597,412 | 64.2% |
| 2025-02-26 | 350,785 | 9 | 591,702 | 59.3% |
| 2025-02-25 | 519,846 | 630 | 933,707 | 55.7% |
| 2025-02-24 | 282,475 | 2,031 | 794,076 | 35.6% |
| 2025-02-21 | 247,929 | 16 | 409,830 | 60.5% |
| 2025-02-20 | 252,366 | 225 | 446,661 | 56.5% |
| 2025-02-19 | 536,424 | 372 | 780,783 | 68.7% |
| 2025-02-18 | 260,449 | 3,440 | 432,994 | 60.2% |
| 2025-02-14 | 243,127 | 0 | 382,736 | 63.5% |
| 2025-02-13 | 232,386 | 26 | 355,138 | 65.4% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.